Comparison

Bupivacaine European Partner

Item no. TMO-T0030L-100mg
Manufacturer TargetMol
CASRN 38396-39-3
Amount 100 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 1 g 500 mg 50 mg
Category
Type Chemicals
Specific against other
Smiles CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias AH 250,AH-250,AH250,Bupivacaina,Exparel,Anekain
Shipping Condition Cool pack
Available
Manufacturer - Targets
Sodium Channel|||NMDAR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
288.43
Description
Bupivacaine (AH-250) is a NMDA receptor inhibitor.Bupivacaine can block sodium, L-calcium, and potassium channels.Bupivacaine potently blocks SCN5A channels with the IC50 of 69.5 μM. Bupivacaine can be used for the research of chronic pain.
Pathways
Neuroscience|||Membrane transporter/Ion channel

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close